For Life Sciences &
Pharma

Genetico helps program teams spend less time wrangling site data and more time advancing rare disease programs

Document processed
HPO ExtractionAuto
  • HP:0001250 · Seizures
  • HP:0000924 · Skeletal anomaly
  • HP:0004322 · Short stature
Rapid ScoreAI · Ranked
Marfan Syndrome94%
Ehlers-Danlos Synd.67%

The Problem

The Program Burden

Pharma and medical affairs teams spend disproportionate time on data reconciliation, cohort building, and manual reporting — time that should go to program delivery.

INTAKE

Site data arrives in inconsistent formats

Program teams manually reconcile referrals, lab reports, and site submissions. Formats vary across centers and geographies.

How It Works

How Genetico Solves It

Program teams currently rely on disconnected site exports, unstructured notes, and ad-hoc spreadsheets. Every study starts from scratch. No consistency across sites.

01

PROGRAM STANDARDIZATION

Standardized Site Data Capture

Structured, guided data capture across participating sites — demographics, phenotypes, family history, and investigations. Consistent across every center in the network.

Faster site onboarding with shared clinical workflows

Patient Intake — Step 3 of 5

HPO TERMS

Seizures HP:0001250×Hypotonia HP:0001290×Ataxia HP:0001251×+ Add term

SYMPTOM ONSET

Infancy (0–2 years)

FAMILY HISTORY

NoneAffected siblingUnknown
Form completion60%
02

DATA CAPTURE

OCR & Report Digitisation

Extract structured clinical and genetic data from lab reports, PDFs, and site documents. Eliminates manual re-entry and accelerates cohort readiness.

Eliminates time spent on manual transcription

Document Import

lab_report_aiims_2024.pdf

2.4 MB · Uploaded just now

Done
Extracting structured data100%

IDENTIFIED DATA

  • Gene VariantBRCA2 pathogenic c.5946delT
  • PhenotypeHP:0001250 Seizures
  • PhenotypeHP:0000924 Skeletal anomalies
  • Lab ValueCK: 1,240 U/L ↑ elevated
StructuredHPO TaggedRegistry-Ready
03

REAL-WORLD EVIDENCE

Longitudinal Patient Tracking

Structured patient records persist across visits and studies. Alerts for follow-up gaps. Longitudinal views of disease progression, automatically updated from site data.

No rebuilding of patient history for each analysis

Patient Timeline
AS

Ananya Sharma

ID: GEN-2024-041 · Rare skeletal dysplasia

Active

Jan 2023

Initial Visit

Jun 2023

Follow-up Consult

Dec 2023

Diagnosis Confirmed

Aug 2024

Follow-up Due

PENDING

LAST NOTE — DEC 2023

Skeletal dysplasia confirmed. NPRD report filed. Next review in 8 months.

Follow-up due Aug 2024
Schedule

Results

Measurable Outcomes

Concrete, quantifiable impact across the areas that matter most for rare disease program teams.

0%BETTER

TIME SAVED

Weeks→Days

  • Manual site data reconciliation
  • Automated structured extraction
0%BETTER

COHORT QUALITY

Ad hoc→RAPID Score

  • Fragmented, inconsistent criteria
  • Evidence-ranked, reproducible
0%BETTER

DATA AVAILABILITY

Siloed→Trial-Ready

  • Limited real-world output
  • Structured program dataset

Built for rare disease
program teams

Connect with us to explore how Genetico supports pharma workflows.

Book a Demo